Category Archives: Uncategorized

Briefing speakers, report: antibiotic resistant infections “pose a catastrophic threat to people in every country”

By on .

When Rep. Gene Green (D-TX) practiced as an attorney in Texas during the 1980s, some of his clients had become infected with tuberculosis that had become resistant to the first and best line of treatment. He had to talk to them through walls to avoid exposure to the disease, he said, often having to shout […]

Haitian prison an incubator for disease, but treatment for multidrug-resistant TB remains out of reach

By on .

When the January 2010 earthquake cracked the walls of Haiti’s National Penitentiary, the roughly 4,500 prisoners caged inside fled into the streets of Port Au Prince. They left a place built to hold about 1,000 men that had gotten so crowded that prisoners shared sheets turned into hammocks, and window ledges for beds, while others, […]

Community-level preventive TB therapy in South African gold miners fails to bring down overall incidence

By on .

Individuals still saw TB incidence reduction of two-thirds, but effect was not durable

Preliminary results from the Thibela Project – which looked at whether community-wide provision of isoniazid preventive therapy (IPT) in South African gold mines would improve TB control in these high-incidence sites…

CDC economic models show HIV treatment scale-up is cost-effective, can save money over time

By on .

New economic modeling shows that scaling up antiretroviral therapy (ART) for HIV/AIDS treatment and prevention in the developing world not only saves lives, but saves money too. Dr. John Blandford of  the Centers for Disease Control and Prevention’s Center for Global Health and his team of colleagues have found that cost savings from averted negative […]

Engaging Indian industry in TB diagnostic innovations

By on .

The following is a guest blog post by Drs. Madhukar Pai and Nora Engel. A recent conference at St. John´s Research Institute (SJRI) in Bangalore, India brought together for the first time more than 200 representatives from industry, government, donors, academia, civil society and the media to discuss what it takes to innovate in tuberculosis […]

Improving TB diagnosis in India: What will it take?

By on .

The following is a guest blog post by Dr. Madhukar Pai, a professor and TB researcher based at McGill University in Montreal, Canada. He serves as co-chair of the Stop TB Partnership’s New Diagnostics Working Group (NDWG), and as a consultant to the Bill & Melinda Gates Foundation (BMGF).

Here is a real story that played out in India. 25-year-old Mohan from Chhattisgarh state had been ill with cough, fever, and weight loss for a number of weeks. He had all the classic symptoms of TB when he went to a private doctor in his town for help. The doctor advised him to… (Read More)

Groundbreaking GeneXpert may evolve to measure HIV viral load in addition to TB diagnostic capacity

By on .

Cepheid, a California-based molecular diagnostics company, and the Foundation for Innovative New Diagnostics (FIND) announced a new collaboration to accelerate the development of a rapid HIV viral load test.  This viral load test will run on the platform of Cepheid’s GeneXpert, the ground-breaking rapid test to diagnose drug-susceptible and drug-resistant tuberculosis.  Given the high rates […]

Guest post: “Treating MDR-TB is imperative”

By on .

This is a guest post by two doctors with vast experience in treating multi-drug resistant tuberculosis (MDR-TB), Drs. Salmaan Keshavjee and Paul Farmer. Farmer is co-founder of Partners In Health and Keshavjee has treated MDR-TB patients through Partners In Health programs for the last decade. Until three months ago, Keshavjee was the chairman of the Green Light Committee of the Stop TB Partnership, which oversaw the distribution of second-line TB drugs to countries. They wrote this post in response to an interview on Science Speaks with Dr. Ezekiel “Zeke” Emanuel, a senior Obama administration official at the Office of Management and Budget. (Emanuel’s interview can be found here.)

Tackling TB to reach MDG targets: The promise of new vaccines

By on .

The following is a guest blog posting by Peg Willingham, the Senior Director of the Aeras Global TB Vaccine Foundation. World leaders are meeting at the United Nations in New York this week to discuss the ambitious global poverty reduction agenda set forth in the Millennium Development Goals (MDGs).  With five years left in the timeline […]

Now, the scientists’ take on HIV and TB

By on .

Welcome to our live blog just across from the U.S. Capitol, where more than 100 HIV and TB scientists, policymakers, and advocates have come together for a symposium titled “Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis.” Two back-to-back sessions—sponsored by the Center for Global Health Policy and the Global Health Council—will feature […]